ISGIDAR 2021 Virtual

Greetings ISGIDARians,

What a long, strange year it has been!

This year’s annual meeting will be held virtually, on the same online platform as CPDD. We greatly appreciate the support and generosity extended to us by CPDD and the Parthenon Management Group for our virtual meeting.

The meeting will be held on Friday, June 18th from 12-4pm (Eastern Time) and the Business meeting from 4-5pm (Eastern Time) instead of the usual Saturday before CPDD. Steve Negus has graciously agreed to give an invited lecture, and we are expecting the usual mix of presentations on preclinical and clinical research.

We are now enthusiastically accepting ideas for mini-symposia, original research, and “favorite paper” presentations as well as applications for travel awards. The registration fee for this year’s meeting has been significantly reduced to $25 (from $100) for regular attendees and is free of charge (from $50) for in-training attendees. We are pleased to be able to offer three travel awards this year. As usual, we will be offering the ISGIDAR Travel Award. In addition, last year we did not give out a William Woolverton Memorial Travel Award due to the meeting being canceled, so we will be giving out two of these awards in 2021, one for preclinical research and one for clinical research. Many thanks to the generous support of Suzette Evans and Richard Foltin, who again sponsored the ISGIDAR Travel Award, as well as Karen Anderson, Kevin Freeman, Sally Huskinson, Mike Nader and James Rowlett, who have recently sponsored the William Woolverton Memorial Travel Award. Please encourage your graduate students and postdoctoral fellows to apply for these prestigious awards!

Details about registering, submitting to the scientific program, and travel awards content are included below. Additional details can be found in this year’s newsletter. We look forward to seeing everyone in June!!

How to Register for ISGIDAR 2021

CPDD will be handling registration this year, and given that our meeting will be held virtually, registration fees are markedly reduced for regular ISGIDAR attendees (only $25) and are free of charge for trainees. If you have any registration issues, please email and Parthenon Management Group would be happy to personally help you

Instructions to Register for the ISGIDAR meeting are as follows:

  • Visit
  • Click Register Now
  • Log In or create a New User account and proceed
  • When selecting a registration type, select ISGIDAR Only if you only want to register for the ISGIDAR Annual Meeting. If you would like to attend the CPDD Annual Meeting, you will have the ability to add ISGIDAR during the next step. If you have already registered for the CPDD Annual Meeting, email to add the ISGIDAR Annual Meeting to your registration.
  • Complete the registration prompts.

How to Submit to the ISGIDAR 2021 Scientific Program

This is a call for presentations (original research, symposia, and “favorite paper” reviews) for the annual ISGIDAR meeting on Friday, June 18th. All submissions will be virtual presentations and should be sent to Josh Lile (


ORIGINAL RESEARCH SUBMISSIONS: For those wishing to make an original research presentation, please submit (1) a title of the talk, (2) a list of all authors, and (3) a brief (2-3 sentence) description of the talk.

SYMPOSIA SUBMISSIONS: For those wishing to submit a symposium, please send (1) a title of the symposium, (2) a brief (2-3 sentence) description, and (3) a list of the individual speakers and titles of their talks.

“FAVORITE PAPER” REVIEW SUBMISSIONS: To encourage participation by those individuals who might not have new drug self-administration data to share (especially trainees!), and to highlight those seminal publications that shaped our careers, we are offering the opportunity for review presentations of “favorite papers”. Please submit (1) the citation and (2) a brief (2-3 sentence) description of the paper.

REVIEW: The executive committee will review submissions. Notifications of acceptance will be made promptly on a rolling basis. Notification of presentation times will be made when the final program is finalized, approximately 2 weeks prior to the annual meeting.

How to Submit to at Travel Award to ISGIDAR 2021

This year, ISGIDAR will sponsor three competitive travel awards, the ISGIDAR Travel Award and two Bill Woolverton Memorial Travel Awards (one for preclinical research and one for clinical research), for trainees present a paper at the virtual ISGIDAR meeting on Friday, June 18th. Awardees will receive professional development funds.

Those who do not receive the award, but who receive good reviews will be encouraged to present their papers at the ISGIDAR meeting.


ELIGIBILITY: Currently a post-baccalaureate, graduate student, or post-doctoral fellow.

PAPER SUBMISSION: Electronic submissions are required (Microsoft word, or less desirable, a pdf).  Submit a short paper (maximum of 1500 words, not including references, and a single figure) describing your study (Abstract, Introduction, Methods, Results, Discussion, with the Abstract limited to 200 words) to Matt Banks ( Pilot projects with few subjects are also acceptable, if the findings are interesting. The scope of the paper should be consistent with a 20-min slide presentation.  Please include paper title, name, mailing address, email and phone number

REVIEW: Papers will be reviewed by ISGIDAR officers for scientific contribution, originality, methodology, and clarity.


REMINDER: If you have updated contact information or know of colleagues who have recently moved, please assist us in forwarding this information on and encouraging them to reach out to us with their new contact information!

ISGIDAR always welcomes TAX-DEDUCTIBLE CONTRIBUTIONS. If you would like to make a tax-deductible contribution go to

Note: Our content management system occasionally places third-party advertisements on this website. ISGIDAR does not receive income from these advertisements and does not endorse their content.

ISGIDAR CPDD Meeting 2021!

June 18, 2021
38 days to go.


The mission of ISGIDAR is to promote interest in, and to facilitate the dissemination of, new information related to drugs as reinforcers, especially as it may relate to human drug abuse.